ICBA Views Misguided IP Waiver as Block to Innovation and Ineffective in Addressing COVID-19 Pandemic
Oliver Schacht, Chair of the International Council of Biotechnology Associations, released the following statement in response to a decision by the World Trade Organization (WTO) Ministerial Conference (MC12) to endorse a COVID-19 vaccine intellectual property waiver: